A deeper understanding of osteosarcoma, the most common primary malignant bone tumor affecting children and adolescents, is ...

This is why T cell exhaustion is a significant hurdle in overcoming resistance. Constant exposure to the unfriendly and immunosuppressive environment around the tumor impairs white blood T cells ...

A study has revealed why some patients don’t respond to immune checkpoint blockade (ICB) therapy for solid cancer tumours and ...

J INTS BIO, a company specializing in the development of therapeutics for cancer and rare diseases, officially announced ...

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer. The more common BRCA wild-type (wt) subtype is particularly resistant to standard treatments such as gemcitabine and ...

It’s the foundation for overcoming resistance, and it’s a vital skill I now teach to leaders in healthcare, education, and beyond. Here are the steps I took—and that you can take—to ...

Susan L. Ravnan, PharmD, Marcus C. Ravnan, PharmD, Prakash C. Deedwania, MD; Domenic A. Sica, MD, Prakash C. Deedwania, MD, Editors ...